Pandemics & Infectious Diseases
Pollution
Medical Treatment & Drug Development
Antimicrobials, Antibiotics & Drug Resistances
Post-Doctoral Fellowships
United Kingdom
2014.12.31
Mitigating the risks of plasmid mediated antibiotic resistance
Michelle
BUCKNER
Institution
University of Birmingham
Country
United Kingdom
Nationality
Canadian
Related articles
Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO
Hôpital Necker-Enfants Malades
Pollution
Healthcare Systems
Toxic Pollutants & Hazardous Substances
Public Health & Health Policy
Air Quality
Water Quality
AXA Award
Switzerland
Grand Jet d'Or Award on Adverse Effects of Pollution on Humans
The World Health Organization estimates that exposure to air pollution is responsible for about 7 million premature deaths worldwide each... Read more
Geneva Health Forum
(GHF)
Geneva Health Forum
Medical Treatment & Drug Development
Drug Delivery
Biotech- and Nanotechnology
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more
Laurence
SABATIER